Teva rebuffs EU pay-for-delay charge at hearing

BRUSSELS (Reuters) – Israeli drugmaker Teva rebuffed EU antitrust charges of making an illegal deal with rival Cephalon to delay selling a cheaper generic version of the latter’s sleep disorder drug at a hearing on Tuesday.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *